|Bid||49.10 x 1200|
|Ask||49.11 x 1000|
|Day's range||48.96 - 49.42|
|52-week range||44.76 - 54.26|
|Beta (5Y monthly)||0.40|
|PE ratio (TTM)||8.52|
|Forward dividend & yield||1.93 (3.70%)|
|Ex-dividend date||03 May 2021|
|1y target est||63.40|
The unit, Express Scripts, said it expects cost savings of $20 million in 2022 by preferring the Semglee injection. Drugmakers such as Eli Lilly, Sanofi and Novo Nordisk have been under pressure to make their insulin products more affordable amid heavy criticism from lawmakers and patients in a country with a diabetes problem.
Dr. Stella Safo, NYC-based HIV Primary Care Physician, joins Yahoo Finance to discuss the latest in the coronavirus pandemic.
Dr. Rishi Desai, Chief Medical Officer at Osmosis & Former Center for Disease Control and Prevention Epidemic Intelligence Officer, joins Yahoo Finance to discuss the latest in the coronavirus pandemic.